Prognostic Significance of Persistent Mediastinal Metastasis Following Induction Therapy in Large (> or = 2 cm) N2 or N3 Non-Small Cell Lung Cancer

Japanese Journal of Thoracic and Cardiovascular Surgery

Volumn 51, Issue 4, 2003, Pages 123-129

  Sawabata, Noriyoshi ^a   Ohta, Mitsunori ^b   Maeda, Hajime ^a   Takeda, Shin Ichi ^a   Hirano, Hiroshi ^a   Okumura, Yoshitomo ^a   Asada, Hiroki ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Induction therapy; Mediastinal lymph node; Non small cell lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE; MITOMYCIN; VINCA ALKALOID;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MEDIASTINUM LYMPH NODE; MEDIASTINUM METASTASIS; MULTIVARIATE ANALYSIS; PROGNOSIS; ARTICLE; LUNG TUMOR; LYMPH NODE METASTASIS; MEDIASTINUM TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; REMISSION; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 0037527860     PISSN: 13444964     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-003-0047-y     Document Type: Conference Paper

References (30)

1. Goldstraw P, Mannam G, Kaplan D, Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994; 107: 19-28.
2. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, Tatsuzawa Y, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991; 51: 253-61.
3. Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases: The Leuven Lung Cancer Group. Ann Thorac Surg 1997; 63: 1441-50.
4. Weisenburger T. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung: The Lung Cancer Study Group. N Engl J Med 1986; 315: 1377-81.
5. Holmes EC, Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986; 4: 710-5.
6. Naruke T, Goya T, Tsuchiya R, Suematsu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-7.
7. Martini N, Kris MG, Flehinger BJ, Gralla RJ, Bains MS, Burt ME, et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55: 1365-74.
8. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 1997; 15: 712-22.
9. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis. Ann Thorac Surg. 1992; 53: 992-8.
10. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330: 153-8.
11. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673-80.
12. Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992; 10: 1237-44.
13. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13: 1880-92.
14. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 1998; 16: 622-34.
15. Rice TW, Adelstein DJ, Ciezki JP, Becker ME, Rybicki LA, Farver CF, et al. Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer. Ann Thorac Surg 1998; 66: 1909-14.
16. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. Induction therapy for non-small cell lung cancer with involved mediatinal nodes in multiple stations. Chest 2000; 118: 123-8.
17. Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000; 70: 1826-31.
18. Sugarbaker DJ, Herndon J, Kohman LJ, Krasna MJ, Green MR. Results of cancer and leukemia group B protocol 8935: a multi-institutional phase II trimodality trial for stage IIIA (N2) non-small cell lung cancer. J Thorac Cardiovasc Surg 1995; 109: 473-85.
19. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
20. Tisi GM, Friedman PJ, Peters RM, Pearson G, Carr D, Lee RE, Selawry O. Clinical staging of primary lung cancer. Am Rev Resp Dis 1983; 127: 659-64.
21. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-7.
22. Pearson FG. An evaluation of mediastinoscopy in the management of presumably operable bronchial carcinoma. J Thorac Cardiovasc Surg 1968; 55: 617-25.
23. Osada H, Kojima K, Tsukada H, Nakajima Y, Imamura K, Matsumoto J. Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer. Jpn J Thoracic Cardiovasc Surgery 2001; 49: 1-10.
24. Landreneau RJ, Hazelrigg SR, Mack MJ, Fitzgibbon LD, Dowling RD, Acuff TE, et al. Thoracoscopic mediastinal lymph node sampling: Useful for mediastinal lymph node stations inaccessible by cervical mediastinoscopy. J Thorac Cardiovasc Surg 1993; 106: 554-8.
25. Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, et al. Phase III study of concurrent vs sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999; 17: 2692-9.
26. Mateu-Navarro M, Rami-Porta R, Bastus-Piulats R, Cirera-Nogueras L, Gonzalez-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 2000; 70: 391-5.
27. Olsen PS, Stentoft P, Ellefsen B, Pettersson G. Re-mediastinoscopy in the assessment of resectability of lung cancer. Eur J Cardiothorac Surg 1997; 11: 661-3.
28. Rong F, Cui B. CT scan directed transbronchial needle aspiration biopsy for mediastinal nodes. Chest 1998; 114: 36-9.
29. Fritscher-Ravens A, Soehendra N, Schirrow L, Sriram PV, Meyer A, Hauber HP, et al. Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer. Chest 2000; 117: 339-45.
30. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (> 3 cm) lymph node lesions. Chest 2000; 117: 773-8.